Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

89
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
89
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

335
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
335
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

283
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
283
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

3.3K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.3K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

308
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
308
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

409
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
409

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of biphoton states in ghost imaging with multiple objects.

Optics express·2026
Same author

Elevated risk of hepatitis E virus infection among sheep smallholders in Xinjiang, China.

One health (Amsterdam, Netherlands)·2026
Same author

Serosurvey of tuberculosis in wild boars in Xinjiang, Northwest China: a pilot study.

Irish veterinary journal·2026
Same author

Molecular biomarkers of sintilimab plus lenvatinib in hepatitis-B-virus-associated hepatocellular carcinoma.

World journal of hepatology·2025
Same author

Dosimetric and hematological toxicity analyses of bone marrow-sparing intensity-modulated radiation therapy for patients with cervical cancer treated with extended-field radiation therapy.

Precision radiation oncology·2025
Same author

Polymer-specific transformation of microplastics under soil freeze-thaw versus UV aging: Multiscale insights into atrazine interaction mechanisms.

Environmental pollution (Barking, Essex : 1987)·2025

Related Experiment Video

Updated: Mar 31, 2026

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.9K

[Pharmacokinetics Study on Curcumin Hydroxypropyl-β-Cyclodextrin Phospholipid Complex in Rats].

Jian-chun Luo, Xue-yuan Hu, Jian-yong Wu

    Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials
    |October 27, 2015
    PubMed
    Summary

    The novel curcumin hydroxypropyl-β-cyclodextrin phospholipid complex significantly enhances curcumin absorption in rats compared to other formulations. This improved pharmacokinetic profile suggests greater bioavailability for this advanced curcumin delivery system.

    More Related Videos

    Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
    06:39

    Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

    Published on: October 27, 2023

    1.6K
    Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
    14:57

    Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

    Published on: October 10, 2020

    15.4K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
    05:08

    Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

    Published on: September 20, 2017

    17.9K
    Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
    06:39

    Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

    Published on: October 27, 2023

    1.6K
    Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
    14:57

    Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

    Published on: October 10, 2020

    15.4K

    Area of Science:

    • Pharmacology
    • Drug Delivery Systems
    • Natural Product Chemistry

    Background:

    • Curcumin, a potent natural compound, suffers from poor bioavailability.
    • Cyclodextrins and phospholipid complexes are known strategies to improve drug solubility and absorption.
    • Combining hydroxypropyl-β-cyclodextrin with phospholipid complex may offer synergistic benefits for curcumin delivery.

    Purpose of the Study:

    • To compare the in vivo pharmacokinetics of different curcumin complex formulations.
    • To evaluate the efficacy of hydroxypropyl-β-cyclodextrin phospholipid complex as a carrier for curcumin.
    • To determine the impact of formulation on curcumin absorption and bioavailability.

    Main Methods:

    • Pharmacokinetic study conducted in Sprague-Dawley (SD) rats.
    • Oral administration of curcumin formulations and free curcumin at a dose of 50 mg/kg.
    • Quantification of blood curcumin concentrations using High-Performance Liquid Chromatography (HPLC).

    Main Results:

    • The curcumin hydroxypropyl-β-cyclodextrin phospholipid complex exhibited the highest AUC0-∞ (1126.20 ± 323.24 µg/(L·h)).
    • This represents a 5.89-fold increase compared to free curcumin (191.08 ± 43.27 µg/(L·h)).
    • The complex also showed superior absorption compared to curcumin phospholipid complex and curcumin hydroxypropyl-β-cyclodextrin.

    Conclusions:

    • Curcumin hydroxypropyl-β-cyclodextrin phospholipid complex demonstrates superior absorption properties.
    • This formulation is more effective in enhancing curcumin bioavailability than simpler complexes.
    • The combined carrier system offers significant advantages for improving curcumin's therapeutic potential.